MELFI, ROSETTA
 Distribuzione geografica
Continente #
AS - Asia 2.852
NA - Nord America 545
EU - Europa 220
AF - Africa 3
OC - Oceania 2
SA - Sud America 2
Totale 3.624
Nazione #
SG - Singapore 2.596
US - Stati Uniti d'America 539
CN - Cina 186
IT - Italia 55
HK - Hong Kong 53
DE - Germania 46
CZ - Repubblica Ceca 41
GB - Regno Unito 30
NL - Olanda 21
FI - Finlandia 8
IN - India 7
CA - Canada 4
FR - Francia 4
LT - Lituania 3
ZA - Sudafrica 3
AU - Australia 2
BR - Brasile 2
JP - Giappone 2
LU - Lussemburgo 2
MX - Messico 2
NO - Norvegia 2
SE - Svezia 2
AL - Albania 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UA - Ucraina 1
VN - Vietnam 1
Totale 3.624
Città #
Ashburn 324
Singapore 57
Hefei 56
Hong Kong 51
Boardman 38
Dallas 34
Brno 32
Rome 30
Munich 29
Beijing 28
London 25
Council Bluffs 19
Shanghai 18
Amsterdam 14
Los Angeles 14
Olomouc 9
Washington 9
West Jordan 8
San Francisco 6
Helsinki 5
Bengaluru 4
Hanover 4
Santa Clara 4
Xi'an 4
Zhengzhou 4
Brooklyn 3
Guangzhou 3
Nuremberg 3
Turku 3
Aversa 2
Bologna 2
Borås 2
Boston 2
Chicago 2
Ciampino 2
Durham 2
Hamar 2
Handan 2
Jinan 2
Johannesburg 2
Luxembourg 2
Melbourne 2
Milan 2
New York 2
North Bergen 2
Qingdao 2
Seattle 2
Shenyang 2
Shijiazhuang 2
São Paulo 2
Tokyo 2
Xiamen 2
Xiangtan 2
Zhoukou 2
Ankara 1
Annapolis 1
Anyang 1
Ardea 1
Atlanta 1
Baoding 1
Bazhou 1
Berlin 1
Bishkek 1
Bismarck 1
Bratislava 1
Buffalo 1
Calgary 1
Central 1
Centurion 1
Changsha 1
Changzhou 1
Chennai 1
Chongqing 1
Concord 1
Frankfurt am Main 1
Ganzhou 1
Goodyear 1
Haikou 1
Halfweg 1
Harbin 1
Harrisburg 1
Hohhot 1
Las Vegas 1
Liaocheng 1
Meizhou 1
Mexico City 1
Miami 1
Milwaukee 1
Minneapolis 1
Mirabella Eclano 1
Nanchang 1
Nanyang 1
Ningbo 1
Oklahoma City 1
Phú Thọ 1
Pune 1
Raleigh 1
Riyadh 1
San Jose 1
Shaoxing 1
Totale 934
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 409
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 210
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 204
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 200
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 200
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 198
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 193
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 191
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 183
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 166
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation 159
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 152
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 140
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 92
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 91
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 91
Correlation between glycemic variability assessed by CGM and short-term outcome in patients undergoing percutaneous coronary intervention 88
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes 86
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 84
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 83
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 82
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 82
Invasive Assessment of Coronary Microvascular Function 76
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 66
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 38
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 29
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 26
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 23
Totale 3.642
Categoria #
all - tutte 12.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 0 0 0 0 0 0 0 0 1 7 27
2022/202337 2 0 2 8 5 0 1 0 0 0 19 0
2023/2024450 2 9 13 15 10 44 23 258 18 17 7 34
2024/20252.911 39 8 46 20 14 43 32 8 56 134 1.204 1.307
2025/2026209 104 90 15 0 0 0 0 0 0 0 0 0
Totale 3.642